Department of Cell and Cancer Biology

Department of Cell and Cancer Biology Postdoc Profiles

Postdoctoral fellows

 Photo of Dr. Himadri Biswas

Himadri Biswas, Ph.D.pm

Zou lab, BHS 440, (419) 383-4164
himadri.biswas@utoledo.edu

Education:
B.S., 2004 - Microbiology, University of Calcutta, Kolkata, West Bengal, India
M.S., 2006 - Biotechnology, University of Burdwan, Purba Bardhaman, West Bengal, India
Ph.D., 2016 - Biochemistry, Univ of Calcutta, Kolkata, West Bengal, India

Research Interests:  Eludicating the structure-function relationships of ATR (ataxia telangiectasia and Rad3-related) prolyl isomers on carcinogenesis and tumorigenesis
Photo of Dr. Megan Dreier

Megan Dreier, Ph.D.pm

de la Serna lab, BHS 303, (419) 383-4133
megan.dreier@utoledo.edu

Education
B.S., 05/2007 - Biology, University of Toledo, Toledo, Ohio
Ph.D., 05/2012 - Cell and Molecular Biology, University of Toledo

Research interests:  Cell cycle and tumor biology; currently studying the effects of the inhibition of chromatin regulators on melanocyte development in melanoma 

Photo of Dr. Shruti Ghai

Shruti Ghai, Ph.D.pm

Su lab, BHS 466, (419) 383-4159 
shrutirakesh.ghai@utoledo.edu

Education

B.Tech, 2016 - D.Y. Patil University, Navi Mumbai, India
M.S., 2017 - Georgetown University, Washington, DC, USA
Ph.D., 2024 - University of Toledo, Cell & Cancer Biology, Toledo, OH, USA

Photo of Dr. Guoyi Jiang

Guoyi Jiang, Ph.D.pm

S-H Liu lab, HEB 225, (419) 383-6489
guoyi.jiang@utoledo.edu

Education

Ph.D., 2024 - Pharmaceutics, University of Houston, College of Pharmacy, Houston, TX
M.Med., 2017 - Pharmaceutical Analysis, Nanjing Medical University, Nanjing, China
B.S., 2014 - Pharmacy, Nanjing Medical University, Nanjing, China

Research interests:   

I aim to innovate cancer therapy by harnessing exosomes as programmable drug delivery vehicles. My research integrates molecular engineering, tumor immunology, and bioanalytical science to overcome biological barriers in pancreatic cancer. I design targeting peptides to enhance specificity and minimize immune clearance. Through advanced models and pharmacokinetic tools, I translate bench discoveries toward personalized medicine. My goal is to bridge nanotechnology and oncology for smarter, safer therapeutics.
 picture of Dr. Shobhit Srivastava

Shobhit Srivastava, Ph.D.                                                                                               

pubmed

Raman lab, BHS 405, (419) 383-4165
shobhit.srivastava@utoledo.edu

Education:
BPharm.,  2008 - Uttar Pradesh Technical University, Lucknow, India
MPharm., 2010 - Uttar Pradesh Technical University, Lucknow, India
Ph.D., 2017 - King George's Medical University, Lucknow, India

Research Interests:  Elucidation of mechanistic basis for drug-resistance mechanism in metastatic triple-negative breast cancer (mTNBC) with an emphasis on targeting translation of oncogenic mRNAs; pharmaceutical chemistry, drug design, evaluation of drug toxicity and metabolomics

Photo of Dr. Harshini Vemula

Harshini  Vemula, Ph.D.pm

Saladi lab, BHS 371, (419) 383-6572
harshini.vemula@utoledo.edu

Education:
B.V.Sc., A.H. 2014 - Sri Venkateswara Veterinary University, Tirupati, India
M.V.Sc., 2017 - Sri Venkateswara Veterinary University, Tirupati, India
Ph.D., 2021 - Tamil Nadu Veterinary and Animal Sciences University, Chennai, India

Research Interests:  Understanding mechanisms by which deregulated epigenetic factors (KDM4A and ACTL6A) promote oncogenic transcriptional program.

Photo of Dr. Yang Wang

Yang Wang, Ph.D.pm

Jianmin Zhang lab, BHS 467, (419) 383-4168
yang.wang4@utoledo.edu

Education:

B.S., 2018 - Preventive Medicine, Shaanxi University of Chinese Medicine, Xianyang, China
M.S., 2020 - Immunology, Xi’an Jiaotong University, Xi’an, China
Ph.D., 2025 - Immunology, Xi’an Jiaotong University, Xi’an, China
 

Research InterestsTumor immunology and chemotherapy resistance, with a focus on how tumor cells evade immune responses and acquire drug resistance. Interested in the role of exosomes, tumor microenvironment interactions, and key molecular pathways in mediating immune escape and therapeutic resistance, aiming to develop effective combination treatment strategies.

 Xunzhen Zheng

Xunzhen (Sean) Zheng, M.D.pm

JT Zhang lab, BHS 435, (419) 383-4322
xunzhen.zheng@utoledo.edu

Education:
M.S., M.D., 06/1997 - Hematology, Central South Univ, Xiangya Medical College, Changsha, Hunan, China

Research Interests:  The involvement of nitric oxide pathway in breast cancer development and treatment

Last Updated: 3/23/26